Viewpoints

Lymphoseek: A New "Gold Standard" for Identifying Positive Lymph Nodes?

Lymphoseek: A New "Gold Standard" for Identifying Positive Lymph Nodes?

Lymphoseek has now demonstrated significant efficacy in diagnosis and staging of squamous cell carcinoma of the head and neck.

Identifying Molecular Subtypes of Head and Neck Cancer May Lead to Effective Preventive Treatment

Identifying Molecular Subtypes of Head and Neck Cancer May Lead to Effective Preventive Treatment

New research has enhanced the understanding of the molecular profile of head and neck squamous cell carcinoma and may point the way to preventive treatment.

Feature Articles

FDG-PET/CT in the Assessment of Treatment Response after Oncologic Treatment of Head and Neck Squamous Cell Carcinoma

FDG-PET/CT in the Assessment of Treatment Response after Oncologic Treatment of Head and Neck Squamous Cell Carcinoma

[Clin Med Insights Ear Nose Throat] FDG-PET/CT is used to monitor treatment response after definitive (chemo)radiotherapy for head and neck squamous cell carcinoma, but its usefulness remains controversial.

Head and Neck Cancer Resources

More Head and Neck Cancer Information

KYPROLIS (carfilzomib) for Refractory Multiple Myeloma

KYPROLIS (carfilzomib) for Refractory Multiple Myeloma

This slideshow reviews drug information for KYROLIS (carfilzomib), indicated for refractory multiple myeloma.
Table of Contents
Slide 3: Indication, Dosage, and Administration
Slide ...

XALKORI® (crizotinib) for Locally Advanced or Metastatic ALK+ NSCLC

XALKORI® (crizotinib) for Locally Advanced or Metastatic ALK+ NSCLC

This slideshow reviews drug information for XALKORI® (crizotinib), indicated for locally advanced or metastatic ALK+NSCLC.

Table of Contents

Slide 3: Indication, Dosage, ...

ARZERRA® (ofatumumab) for Chronic Lymphocytic Leukemia (CLL)

ARZERRA® (ofatumumab) for Chronic Lymphocytic Leukemia (CLL)

This slideshow reviews drug information for ARZERRA® (ofatumumab), indicated for chronic lymphocytic leukemia (CLL).

Table of Contents

Slide 3: Indication, Dosage, and ...

KEYTRUDA® (pembrolizumab) for Unresectable or Metastatic Melanoma

KEYTRUDA® (pembrolizumab) for Unresectable or Metastatic Melanoma

This slideshow reviews drug information for KEYTRUDA® (pembrolizumab), indicated for unresectable or metastatic melanoma.

Table of Contents

Slide 3: Indication, Dosage, and ...

ZYDELIG® (idelalisib) for Relapsed Follicular B-cell Non-Hodgkin Lymphoma (FL)

ZYDELIG® (idelalisib) for Relapsed Follicular B-cell Non-Hodgkin Lymphoma (FL)

This slideshow reviews drug information for ZYDELIG® (idelalisib), indicated for relapsed follicular non-Hodgkin lymphoma (FL).

Table of Contents

Slide 3: Indication, Dosage, ...

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs